Pharma Journalist -

Ajinomoto Bio-Pharma Services announced it will soon open a high speed multi-purpose fill finish line in its state-of-the-art commercial manufacturing facility located in San Diego, CA.…
Read More...

Alloy Therapeutics and Pyxis Oncology announced the formation of a joint venture named Kyma Therapeutics to develop immune-modulating antibodies for novel targets in cancer and…
Read More...

Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma plc announced that they have entered into a definitive agreement under which Xeris will acquire Strongbridge for stock and…
Read More...

Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for BI 425809 for the treatment of Cognitive Impairment…
Read More...

Shanghai Stock Exchange listed company HitGen Inc. (“HitGen”) announced that it has entered into a research collaboration agreement with Dorian Therapeutics, Inc. (“Dorian”), a private…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions for…
Read More...

SMi reports: Have you secured your place at Pre-filled Syringes West Coast 2021 conference returning as a virtual event in June? Now only 3 weeks away there are limited places…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has issued a positive scientific…
Read More...

AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18…
Read More...

The U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of…
Read More...